Tag: HAE
Do You Believe in the Long-Term Growth Potential of Haemonetics Corporation (HAE)?
Loomis Sayles, an investment management company, recently released its third-quarter 2025 investor letter for its Small Cap Value…
Intellia Reports Positive 3-Year Lonvo-z Data in HAE Trial at EAACI Congress
Intellia Therapeutics, Inc. (NASDAQ:NTLA) has recently made headlines as one of the top genomics stocks to buy according…